期刊文献+

高效液相色谱法测定人血浆中9-硝基喜树碱的含量 被引量:4

Determination of 9-nitro-camptothecin in human plasma by HPLC
暂未订购
导出
摘要 目的:建立高效液相色谱(HPLC)法检测人血浆中9-硝基喜树碱的浓度。方法:采用Kromasil C18色谱分析柱,以甲醇-磷酸盐缓冲液(48:52,pH 2.5)作为流动相,流速为1.0mL·min^-1,柱温30℃,检测波长370nm,喜树碱为内标,血浆样品用C18固相萃取小柱处理,采用加权最小二乘法计算回归方程。结果:9-硝基喜树碱的线性范围为5~100μg·L^-1,r=0.9999,最低检测限为5μg·L^-1。该方法的提取回收率为83.5%~114.4%,批间和批内RSD〈15%。结论:该方法简便、准确、重现性好且灵敏度高,适用于9-硝基喜树碱临床人体药动学研究。 OBJECTIVE To establish an HPLC method for the determination of 9-nitro-camptothecin in human plasma. METHODS A kromasil C18 column was used as analytical column. The mobile phase consisted of methanol and phosphate buffer solution(48:52,pH 2. 5). The flow rate was 1.0 mL·min^-1 and the column temprature was at 30℃. Detection wavelength was at 3711 nm. Camptothecin was used as internal standard. Plasma samples were prepared with solid phase extraction assay. RESULTS A linear calibration curve of 9-nitro-camptothecin in plasma was obtained in the concentration range of 5 to 1000μg·L^-1(r= 0. 999 9). The absolute recovery was between 83.5%-114. 4% and the relative recovery is between 84. 0% - 104. 9%. The intra- and inter-run precision was measured to be below 15 %. CONCLUSION The method is shown to be convenient and accurate,and suitable for clinical pharmacokinetic study of 9-nitro-camptothecin.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2006年第4期378-380,共3页 Chinese Journal of Hospital Pharmacy
基金 国家863计划资助项目(课题编号:2004AA2Z3720)
关键词 9-硝基喜树碱 高效液相色谱法 固相萃取 9-nitro-camptotheein(9-NC) HPLC solid phase extraction
  • 相关文献

参考文献7

  • 1Zamboni WC,Jung LL,Egorin MJ,et al.Relationship between plasma exposure of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite and antitumor response in mice bearing human colon carcinoma xenografts[J].Clin Cancer Res,2005,11(13):4867-74.
  • 2Virginine M M Herben,Roel van Gijin,Jan H M,et al.Phase I and pharmacokinetic study of a daily times 5 short intravenous infusion schedule of 9-amino-camptothecin in a colloidaldispersion formulation in patients with advanced solid tumors[J].Journal of Clinical Oncology,1999,17:1906.
  • 3Verschraegen CF,Natelson EA,Giovanella BC,et al.A Phase I and pharmacokinetic study of oral 9-nitro-camptothecin,a novel water-insoluble topoisomerase I inhibitor[J].Anti Cancer Drugs,1998,9(1):36-44.
  • 4Nadja E,Schoemaker,Jan H M,et al.Development of an optimal pharmacokinetic sampling schedule for rubitecan administered orally in a daily times five schedule[J].Cancer Chemother Pharmacol,2002,50:514-517.
  • 5李柯,钟大放.高效液相色谱法测定大鼠组织及血浆中9-硝基喜树碱含量[J].药学学报,2003,38(2):124-128. 被引量:18
  • 6Nadja E,Schoemaker,Hilde Rosing,et al.Determination of 9-nitro-camptothecin and its metabolite 9-amino-camptothecin in human plasma using high-performance liquid chromatography with ultraviolet and fluorescence detection[J].Journal of Chromatography B,2002,775:231-237.
  • 7陈勇川,臧雷,穆海川.固相萃取高效液相色谱法测定人血浆中伊贝沙坦浓度[J].药物分析杂志,2001,21(3):196-197. 被引量:4

二级参考文献7

  • 1Chang S Y,J Chromatogr B,1997年,702卷,149页
  • 2Sawada S, Yokokura T. Synthesis of CPT-11 [J]. Ann NY Acad Sci, 1996,803:13-28.
  • 3Verschraegen CF, Natelson EA, Giovanella BC, et al. A phase I clinical and pharmacological study of oral 9-nitrocamptothecin, a novel water-insoluble topoisomerase I inhibitor [J]. Anti Cancer Drugs, 1998, 9(1):36-44.
  • 4Ahmed AE, Jacob S, Giovanella BC, et al. Comparative disposition of the antineoplastic agent 9-nitrocamptothecin and the inactive isomer 12-nitrocamptothecin in CASE-bearing nude mice: effect of route of administration on tissue distribution [J]. Cancer Chemother Pharmacol, 1997,41(1):29-36.
  • 5Koshkina NV, Gilbert BE, Waldrep JC, et al. Distribution of camptothecin after delivery as a liposome aerosol or following intramuscular injection in mice [J]. Cancer Chemother Pharmacol, 1999,44(3):187-192.
  • 6Stehlin JS Jr, Natelson EA, Hinz HR, et al. Phase I clinical trial and pharmacokinetics resulted with oral administration of 20(S)-camptothecin [A]. Potmesil M. Camptothecins: New Anticancer Agent [M]. Boca Raton: CRC Press, 1995.59-65.
  • 7Ahmed AE, Jacob S, Giovanella BC, et al. Influence of route of administration of 3H-camptothecin distribution and tumor uptake in CASE-bearing nude mice: whole-body autoradiographic studies [J]. Cancer Chemother Pharmacol, 1996,39(1-2):122-130.

共引文献20

同被引文献2658

引证文献4

二级引证文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部